Recent studies suggest that activation of ERK1/2 signaling may convert the growth inhibitory effects of TGF-β1 to more pro-oncogenic effects, and cooperation between the TGF-β1 pathway and activated ERK1/2 signaling is essential for the invasive phenotype in different types of human cancer [26, 29, 33]. Here, MAPK3 is linked to cancer.